Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

EQT to Acquire SPT Labtech for £650m from Battery Ventures (2022-06-22)
> EQT Private Equity to acquire SPT Labtech, a manufacturer and designer of automated instruments and consumables for life science research with a focus on liquid handling, sample management and Cryogenic Electron Microscopy ("Cryo-EM") sample preparation technolog...
AZ: Positive Ph3 Interim Data for Eplontersen in ATTRv-PN (2022-06-21)
New Drug Application filing anticipated based on positive data from interim analysis Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed AstraZeneca ...
Pfizer to Invest €90.5m in Valneva (2022-06-20)
> Pfizer will invest €90.5 million in Valneva > Planned Phase 3 study confirmed to initiate in Q3 2022 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced that they have entered into an Eq...
Genomatica & Unilever Launch $120m Joint Venture (2022-06-16)
> Using Geno’s cutting-edge biotechnology, the venture aims to commercialize and scale plant-based alternatives to feedstocks like palm oil or fossil fuels, to make key ingredients used in everyday cleaning and personal care products. > Unilever’s investment, ...
HTGF’s Fourth Fund Announces First Closing at over €400m (2022-06-14)
> High-Tech Gründerfonds’ fourth fund has already secured more than €400 million in commitments at first closing. > The volume of investment committed has clearly surpassed expectations. Second closing is scheduled to take place later this year. > Forty priva...
MorphoSys & HIBio: Equity Participation & License Agreements (2022-06-14)
> Human Immunology Biosciences (HIBio) is a biotechnology company focused on developing precision medicines for autoimmune and inflammatory diseases, backed by ARCH Venture Partners and Monograph Capital > HIBio obtains exclusive worldwide rights, with the excep...
Spirea Raises £2.4m to Develop ADCs in Cancer (2022-06-14)
> Investment co-led by Jonathan Milner and Cambridge Enterprise > US-based R42 Group, ACF Investors, o2h Ventures, Syndicate Room and the Cambridge Angels investing > Funding will enable the development of Spirea’s pipeline of antibody drug conjugate therap...
Evonetix Appoints Colin McCracken as CEO (2022-06-13)
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect. Colin’s appointment will support the next phase of the ...
Forbion Growth Opportunities Fund II: First Close at €470m (2022-06-09)
Forbion, a leading European life sciences venture capital firm, today announces the first €470 million (USD 500 million) close of its Forbion Growth Opportunities Fund II (“Forbion Growth”), focused on investing in late-stage European life sciences companies, excee...
Relation Therapeutics Raises $25m Seed Round, Appoints CEO (2022-06-09)
DCVC and Magnetic Ventures co-led a $25 million seed financing, with participation from Khosla Ventures, OMERS Ventures, and firstminute Capital, among others Relation Therapeutics, the pioneer of drug discovery using active-graph machine learning (ML) combine...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] Made Without Love 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)